nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—HTR2C—Sorafenib—thyroid cancer	0.153	0.322	CbGbCtD
Tramadol—CYP2B6—Sorafenib—thyroid cancer	0.0952	0.2	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—thyroid cancer	0.0578	0.121	CbGbCtD
Tramadol—CYP3A4—Vandetanib—thyroid cancer	0.0485	0.102	CbGbCtD
Tramadol—CYP2D6—Sorafenib—thyroid cancer	0.046	0.0967	CbGbCtD
Tramadol—CYP3A4—Sorafenib—thyroid cancer	0.0293	0.0615	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—thyroid cancer	0.0279	0.0586	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—thyroid cancer	0.0178	0.0373	CbGbCtD
Tramadol—Muscular weakness—Epirubicin—thyroid cancer	0.000261	0.000506	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000261	0.000506	CcSEcCtD
Tramadol—Dizziness—Sorafenib—thyroid cancer	0.000261	0.000504	CcSEcCtD
Tramadol—Mood swings—Doxorubicin—thyroid cancer	0.00026	0.000503	CcSEcCtD
Tramadol—Abdominal distension—Epirubicin—thyroid cancer	0.000258	0.000499	CcSEcCtD
Tramadol—Ataxia—Doxorubicin—thyroid cancer	0.000258	0.000499	CcSEcCtD
Tramadol—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000257	0.000497	CcSEcCtD
Tramadol—Influenza—Epirubicin—thyroid cancer	0.000256	0.000496	CcSEcCtD
Tramadol—Asthma—Epirubicin—thyroid cancer	0.000256	0.000496	CcSEcCtD
Tramadol—Dysphagia—Epirubicin—thyroid cancer	0.000256	0.000496	CcSEcCtD
Tramadol—Dehydration—Doxorubicin—thyroid cancer	0.000255	0.000493	CcSEcCtD
Tramadol—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000253	0.00049	CcSEcCtD
Tramadol—Dry skin—Doxorubicin—thyroid cancer	0.000251	0.000486	CcSEcCtD
Tramadol—Pancreatitis—Epirubicin—thyroid cancer	0.000251	0.000486	CcSEcCtD
Tramadol—Vomiting—Sorafenib—thyroid cancer	0.00025	0.000485	CcSEcCtD
Tramadol—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00025	0.000485	CcSEcCtD
Tramadol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00025	0.000485	CcSEcCtD
Tramadol—Hypokalaemia—Doxorubicin—thyroid cancer	0.000249	0.000483	CcSEcCtD
Tramadol—Angina pectoris—Epirubicin—thyroid cancer	0.000249	0.000483	CcSEcCtD
Tramadol—Rash—Sorafenib—thyroid cancer	0.000248	0.000481	CcSEcCtD
Tramadol—Dermatitis—Sorafenib—thyroid cancer	0.000248	0.00048	CcSEcCtD
Tramadol—Breast disorder—Doxorubicin—thyroid cancer	0.000248	0.000479	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000247	0.000478	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000247	0.000478	CcSEcCtD
Tramadol—Headache—Sorafenib—thyroid cancer	0.000247	0.000478	CcSEcCtD
Tramadol—Bronchitis—Epirubicin—thyroid cancer	0.000246	0.000477	CcSEcCtD
Tramadol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000245	0.000474	CcSEcCtD
Tramadol—Gastritis—Doxorubicin—thyroid cancer	0.000243	0.00047	CcSEcCtD
Tramadol—Muscular weakness—Doxorubicin—thyroid cancer	0.000242	0.000468	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000242	0.000468	CcSEcCtD
Tramadol—Dysuria—Epirubicin—thyroid cancer	0.000239	0.000463	CcSEcCtD
Tramadol—Abdominal distension—Doxorubicin—thyroid cancer	0.000238	0.000462	CcSEcCtD
Tramadol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000238	0.000461	CcSEcCtD
Tramadol—Dysphagia—Doxorubicin—thyroid cancer	0.000237	0.000459	CcSEcCtD
Tramadol—Asthma—Doxorubicin—thyroid cancer	0.000237	0.000459	CcSEcCtD
Tramadol—Influenza—Doxorubicin—thyroid cancer	0.000237	0.000459	CcSEcCtD
Tramadol—Pollakiuria—Epirubicin—thyroid cancer	0.000237	0.000458	CcSEcCtD
Tramadol—Nausea—Sorafenib—thyroid cancer	0.000234	0.000453	CcSEcCtD
Tramadol—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000234	0.000452	CcSEcCtD
Tramadol—Pancreatitis—Doxorubicin—thyroid cancer	0.000232	0.00045	CcSEcCtD
Tramadol—Weight decreased—Epirubicin—thyroid cancer	0.000232	0.000448	CcSEcCtD
Tramadol—Hyperglycaemia—Epirubicin—thyroid cancer	0.000231	0.000447	CcSEcCtD
Tramadol—Angina pectoris—Doxorubicin—thyroid cancer	0.000231	0.000447	CcSEcCtD
Tramadol—Pneumonia—Epirubicin—thyroid cancer	0.00023	0.000444	CcSEcCtD
Tramadol—Infestation NOS—Epirubicin—thyroid cancer	0.000228	0.000442	CcSEcCtD
Tramadol—Infestation—Epirubicin—thyroid cancer	0.000228	0.000442	CcSEcCtD
Tramadol—Bronchitis—Doxorubicin—thyroid cancer	0.000228	0.000441	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000226	0.000438	CcSEcCtD
Tramadol—Renal failure—Epirubicin—thyroid cancer	0.000224	0.000434	CcSEcCtD
Tramadol—Stomatitis—Epirubicin—thyroid cancer	0.000223	0.000431	CcSEcCtD
Tramadol—Urinary tract infection—Epirubicin—thyroid cancer	0.000222	0.00043	CcSEcCtD
Tramadol—Conjunctivitis—Epirubicin—thyroid cancer	0.000222	0.00043	CcSEcCtD
Tramadol—Dysuria—Doxorubicin—thyroid cancer	0.000222	0.000429	CcSEcCtD
Tramadol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00022	0.000426	CcSEcCtD
Tramadol—Sweating—Epirubicin—thyroid cancer	0.000219	0.000424	CcSEcCtD
Tramadol—Pollakiuria—Doxorubicin—thyroid cancer	0.000219	0.000424	CcSEcCtD
Tramadol—Haematuria—Epirubicin—thyroid cancer	0.000218	0.000421	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000216	0.000419	CcSEcCtD
Tramadol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000216	0.000418	CcSEcCtD
Tramadol—Epistaxis—Epirubicin—thyroid cancer	0.000215	0.000417	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—thyroid cancer	0.000214	0.000415	CcSEcCtD
Tramadol—Sinusitis—Epirubicin—thyroid cancer	0.000214	0.000415	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000214	0.000414	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—thyroid cancer	0.000212	0.000411	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—thyroid cancer	0.000211	0.000409	CcSEcCtD
Tramadol—Infestation—Doxorubicin—thyroid cancer	0.000211	0.000409	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000209	0.000405	CcSEcCtD
Tramadol—Bradycardia—Epirubicin—thyroid cancer	0.000209	0.000404	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—thyroid cancer	0.000208	0.000402	CcSEcCtD
Tramadol—Haemoglobin—Epirubicin—thyroid cancer	0.000206	0.000399	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—thyroid cancer	0.000206	0.000399	CcSEcCtD
Tramadol—Rhinitis—Epirubicin—thyroid cancer	0.000205	0.000398	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—thyroid cancer	0.000205	0.000397	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000205	0.000397	CcSEcCtD
Tramadol—Haemorrhage—Epirubicin—thyroid cancer	0.000205	0.000397	CcSEcCtD
Tramadol—Hepatitis—Epirubicin—thyroid cancer	0.000205	0.000397	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—thyroid cancer	0.000204	0.000395	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—thyroid cancer	0.000203	0.000394	CcSEcCtD
Tramadol—Sweating—Doxorubicin—thyroid cancer	0.000202	0.000392	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—thyroid cancer	0.000202	0.000392	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—thyroid cancer	0.000202	0.000391	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—thyroid cancer	0.000201	0.00039	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—thyroid cancer	0.000201	0.00039	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—thyroid cancer	0.000201	0.000389	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.0002	0.000387	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—thyroid cancer	0.000199	0.000386	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—thyroid cancer	0.000198	0.000384	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—thyroid cancer	0.000197	0.000382	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—thyroid cancer	0.000194	0.000375	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—thyroid cancer	0.000193	0.000374	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—thyroid cancer	0.000192	0.000371	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—thyroid cancer	0.000191	0.00037	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—thyroid cancer	0.000191	0.000369	CcSEcCtD
Tramadol—Flushing—Epirubicin—thyroid cancer	0.00019	0.000368	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—thyroid cancer	0.00019	0.000368	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—thyroid cancer	0.00019	0.000368	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—thyroid cancer	0.00019	0.000367	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—thyroid cancer	0.00019	0.000367	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000189	0.000365	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—thyroid cancer	0.000188	0.000364	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000187	0.000362	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000187	0.000362	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000186	0.000361	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—thyroid cancer	0.000186	0.00036	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—thyroid cancer	0.000186	0.00036	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—thyroid cancer	0.000185	0.000358	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—thyroid cancer	0.000185	0.000358	CcSEcCtD
Tramadol—Chills—Epirubicin—thyroid cancer	0.000184	0.000356	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—thyroid cancer	0.000183	0.000354	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—thyroid cancer	0.000183	0.000354	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—thyroid cancer	0.00018	0.000348	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—thyroid cancer	0.000179	0.000347	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—thyroid cancer	0.000178	0.000345	CcSEcCtD
Tramadol—Erythema—Epirubicin—thyroid cancer	0.000178	0.000345	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—thyroid cancer	0.000177	0.000343	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—thyroid cancer	0.000177	0.000342	CcSEcCtD
Tramadol—Flushing—Doxorubicin—thyroid cancer	0.000176	0.000341	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000176	0.000341	CcSEcCtD
Tramadol—Flatulence—Epirubicin—thyroid cancer	0.000176	0.00034	CcSEcCtD
Tramadol—Tension—Epirubicin—thyroid cancer	0.000175	0.000339	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—thyroid cancer	0.000175	0.000338	CcSEcCtD
Tramadol—Nervousness—Epirubicin—thyroid cancer	0.000173	0.000335	CcSEcCtD
Tramadol—Back pain—Epirubicin—thyroid cancer	0.000173	0.000334	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—thyroid cancer	0.000172	0.000333	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—thyroid cancer	0.000172	0.000332	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—thyroid cancer	0.000171	0.000332	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000171	0.000331	CcSEcCtD
Tramadol—Chills—Doxorubicin—thyroid cancer	0.00017	0.000329	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—thyroid cancer	0.000169	0.000328	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—thyroid cancer	0.000168	0.000325	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—thyroid cancer	0.000166	0.000322	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000166	0.00032	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—thyroid cancer	0.000165	0.00032	CcSEcCtD
Tramadol—Erythema—Doxorubicin—thyroid cancer	0.000165	0.00032	CcSEcCtD
Tramadol—Anaemia—Epirubicin—thyroid cancer	0.000165	0.000319	CcSEcCtD
Tramadol—Agitation—Epirubicin—thyroid cancer	0.000164	0.000317	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—thyroid cancer	0.000163	0.000315	CcSEcCtD
Tramadol—Tension—Doxorubicin—thyroid cancer	0.000162	0.000314	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—thyroid cancer	0.000162	0.000313	CcSEcCtD
Tramadol—Malaise—Epirubicin—thyroid cancer	0.000161	0.000311	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—thyroid cancer	0.00016	0.00031	CcSEcCtD
Tramadol—Vertigo—Epirubicin—thyroid cancer	0.00016	0.00031	CcSEcCtD
Tramadol—Syncope—Epirubicin—thyroid cancer	0.00016	0.00031	CcSEcCtD
Tramadol—Back pain—Doxorubicin—thyroid cancer	0.00016	0.000309	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—thyroid cancer	0.000159	0.000307	CcSEcCtD
Tramadol—Palpitations—Epirubicin—thyroid cancer	0.000158	0.000305	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—thyroid cancer	0.000157	0.000304	CcSEcCtD
Tramadol—Cough—Epirubicin—thyroid cancer	0.000156	0.000301	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—thyroid cancer	0.000156	0.000301	CcSEcCtD
Tramadol—Convulsion—Epirubicin—thyroid cancer	0.000155	0.000299	CcSEcCtD
Tramadol—Hypertension—Epirubicin—thyroid cancer	0.000154	0.000298	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000153	0.000296	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—thyroid cancer	0.000153	0.000295	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—thyroid cancer	0.000152	0.000294	CcSEcCtD
Tramadol—Chest pain—Epirubicin—thyroid cancer	0.000152	0.000294	CcSEcCtD
Tramadol—Myalgia—Epirubicin—thyroid cancer	0.000152	0.000294	CcSEcCtD
Tramadol—Agitation—Doxorubicin—thyroid cancer	0.000152	0.000294	CcSEcCtD
Tramadol—Anxiety—Epirubicin—thyroid cancer	0.000151	0.000293	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000151	0.000292	CcSEcCtD
Tramadol—Discomfort—Epirubicin—thyroid cancer	0.00015	0.00029	CcSEcCtD
Tramadol—Malaise—Doxorubicin—thyroid cancer	0.000149	0.000288	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—thyroid cancer	0.000149	0.000288	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—thyroid cancer	0.000148	0.000287	CcSEcCtD
Tramadol—Syncope—Doxorubicin—thyroid cancer	0.000148	0.000287	CcSEcCtD
Tramadol—Confusional state—Epirubicin—thyroid cancer	0.000147	0.000284	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—thyroid cancer	0.000146	0.000282	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—thyroid cancer	0.000146	0.000282	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000145	0.000281	CcSEcCtD
Tramadol—Infection—Epirubicin—thyroid cancer	0.000145	0.00028	CcSEcCtD
Tramadol—Cough—Doxorubicin—thyroid cancer	0.000144	0.000279	CcSEcCtD
Tramadol—Shock—Epirubicin—thyroid cancer	0.000143	0.000277	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—thyroid cancer	0.000143	0.000277	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—thyroid cancer	0.000143	0.000276	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000143	0.000276	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—thyroid cancer	0.000143	0.000276	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—thyroid cancer	0.000142	0.000275	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—thyroid cancer	0.000141	0.000274	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000141	0.000272	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—thyroid cancer	0.000141	0.000272	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—thyroid cancer	0.000141	0.000272	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—thyroid cancer	0.000141	0.000272	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—thyroid cancer	0.00014	0.000271	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00014	0.00027	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—thyroid cancer	0.000139	0.000269	CcSEcCtD
Tramadol—Anorexia—Epirubicin—thyroid cancer	0.000139	0.000269	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—thyroid cancer	0.000137	0.000266	CcSEcCtD
Tramadol—Hypotension—Epirubicin—thyroid cancer	0.000136	0.000263	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—thyroid cancer	0.000136	0.000263	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000135	0.000261	CcSEcCtD
Tramadol—Infection—Doxorubicin—thyroid cancer	0.000134	0.000259	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000133	0.000257	CcSEcCtD
Tramadol—Shock—Doxorubicin—thyroid cancer	0.000133	0.000257	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000132	0.000256	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000132	0.000255	CcSEcCtD
Tramadol—Insomnia—Epirubicin—thyroid cancer	0.000132	0.000255	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—thyroid cancer	0.000131	0.000255	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—thyroid cancer	0.000131	0.000253	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—thyroid cancer	0.000131	0.000253	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00013	0.000252	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—thyroid cancer	0.00013	0.000251	CcSEcCtD
Tramadol—Somnolence—Epirubicin—thyroid cancer	0.000129	0.000251	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—thyroid cancer	0.000128	0.000249	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—thyroid cancer	0.000128	0.000248	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—thyroid cancer	0.000127	0.000245	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—thyroid cancer	0.000126	0.000244	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000126	0.000243	CcSEcCtD
Tramadol—Fatigue—Epirubicin—thyroid cancer	0.000126	0.000243	CcSEcCtD
Tramadol—Pain—Epirubicin—thyroid cancer	0.000124	0.000241	CcSEcCtD
Tramadol—Constipation—Epirubicin—thyroid cancer	0.000124	0.000241	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000123	0.000238	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—thyroid cancer	0.000122	0.000236	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—thyroid cancer	0.000121	0.000234	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—thyroid cancer	0.00012	0.000232	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—thyroid cancer	0.00012	0.000232	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—thyroid cancer	0.00012	0.000232	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000119	0.00023	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—thyroid cancer	0.000119	0.00023	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—thyroid cancer	0.000117	0.000227	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000116	0.000225	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—thyroid cancer	0.000116	0.000225	CcSEcCtD
Tramadol—Urticaria—Epirubicin—thyroid cancer	0.000116	0.000224	CcSEcCtD
Tramadol—Pain—Doxorubicin—thyroid cancer	0.000115	0.000223	CcSEcCtD
Tramadol—Constipation—Doxorubicin—thyroid cancer	0.000115	0.000223	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—thyroid cancer	0.000115	0.000223	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—thyroid cancer	0.000115	0.000223	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000111	0.000215	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00011	0.000213	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—thyroid cancer	0.000107	0.000208	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—thyroid cancer	0.000107	0.000207	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—thyroid cancer	0.000106	0.000206	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—thyroid cancer	0.000106	0.000206	CcSEcCtD
Tramadol—Asthenia—Epirubicin—thyroid cancer	0.000104	0.000202	CcSEcCtD
Tramadol—Pruritus—Epirubicin—thyroid cancer	0.000103	0.000199	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—thyroid cancer	9.96e-05	0.000193	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—thyroid cancer	9.92e-05	0.000192	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—thyroid cancer	9.67e-05	0.000187	CcSEcCtD
Tramadol—Dizziness—Epirubicin—thyroid cancer	9.63e-05	0.000186	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—thyroid cancer	9.53e-05	0.000185	CcSEcCtD
Tramadol—Vomiting—Epirubicin—thyroid cancer	9.26e-05	0.000179	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—thyroid cancer	9.22e-05	0.000178	CcSEcCtD
Tramadol—Rash—Epirubicin—thyroid cancer	9.18e-05	0.000178	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—thyroid cancer	9.17e-05	0.000178	CcSEcCtD
Tramadol—Headache—Epirubicin—thyroid cancer	9.12e-05	0.000177	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—thyroid cancer	8.91e-05	0.000172	CcSEcCtD
Tramadol—Nausea—Epirubicin—thyroid cancer	8.65e-05	0.000167	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—thyroid cancer	8.56e-05	0.000166	CcSEcCtD
Tramadol—Rash—Doxorubicin—thyroid cancer	8.49e-05	0.000164	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—thyroid cancer	8.49e-05	0.000164	CcSEcCtD
Tramadol—Headache—Doxorubicin—thyroid cancer	8.44e-05	0.000163	CcSEcCtD
Tramadol—Nausea—Doxorubicin—thyroid cancer	8e-05	0.000155	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—SST—thyroid cancer	2.37e-05	0.00319	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CALCB—thyroid cancer	2.37e-05	0.00318	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—TSHR—thyroid cancer	2.33e-05	0.00313	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	2.3e-05	0.0031	CbGpPWpGaD
Tramadol—OPRM1—IL4-mediated signaling events—AKT1—thyroid cancer	2.3e-05	0.00309	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CALCA—thyroid cancer	2.29e-05	0.00307	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—TSHR—thyroid cancer	2.26e-05	0.00303	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TRIM33—thyroid cancer	2.24e-05	0.00301	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—PTCH1—thyroid cancer	2.23e-05	0.00299	CbGpPWpGaD
Tramadol—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.21e-05	0.00298	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MINPP1—thyroid cancer	2.21e-05	0.00297	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TSHR—thyroid cancer	2.11e-05	0.00284	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PRKAR1A—thyroid cancer	2.08e-05	0.00279	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	2.08e-05	0.00279	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—TSHR—thyroid cancer	2.04e-05	0.00274	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—SST—thyroid cancer	2.04e-05	0.00274	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CALCB—thyroid cancer	2e-05	0.00269	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CALCA—thyroid cancer	1.96e-05	0.00264	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—HRAS—thyroid cancer	1.93e-05	0.0026	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—PTEN—thyroid cancer	1.93e-05	0.00259	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—PTCH1—thyroid cancer	1.92e-05	0.00258	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MINPP1—thyroid cancer	1.9e-05	0.00256	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TRIM33—thyroid cancer	1.89e-05	0.00255	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.88e-05	0.00253	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NDUFA13—thyroid cancer	1.88e-05	0.00253	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TSHR—thyroid cancer	1.85e-05	0.00249	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PRKAR1A—thyroid cancer	1.82e-05	0.00245	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—SST—thyroid cancer	1.81e-05	0.00243	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—RXRA—thyroid cancer	1.8e-05	0.00242	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PTCH1—thyroid cancer	1.8e-05	0.00241	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CHST14—thyroid cancer	1.77e-05	0.00237	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—SST—thyroid cancer	1.76e-05	0.00236	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CALCA—thyroid cancer	1.74e-05	0.00234	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—TSHR—thyroid cancer	1.73e-05	0.00232	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALCB—thyroid cancer	1.72e-05	0.00231	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TCF7L1—thyroid cancer	1.71e-05	0.00229	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—AKT1—thyroid cancer	1.71e-05	0.00229	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CALCA—thyroid cancer	1.69e-05	0.00227	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—SST—thyroid cancer	1.64e-05	0.00221	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TRIM33—thyroid cancer	1.63e-05	0.00219	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NDUFA13—thyroid cancer	1.62e-05	0.00217	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—SST—thyroid cancer	1.59e-05	0.00213	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.58e-05	0.00213	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CALCA—thyroid cancer	1.58e-05	0.00213	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PTCH1—thyroid cancer	1.58e-05	0.00212	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	1.57e-05	0.0021	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	1.54e-05	0.00207	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	1.53e-05	0.00205	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CHST14—thyroid cancer	1.52e-05	0.00204	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	1.5e-05	0.00201	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—TSHR—thyroid cancer	1.48e-05	0.00199	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALCB—thyroid cancer	1.48e-05	0.00199	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—SST—thyroid cancer	1.44e-05	0.00194	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CDK1—thyroid cancer	1.43e-05	0.00192	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HPGD—thyroid cancer	1.42e-05	0.00191	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TRIM33—thyroid cancer	1.4e-05	0.00188	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	1.39e-05	0.00186	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TSHR—thyroid cancer	1.35e-05	0.00181	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—SST—thyroid cancer	1.34e-05	0.0018	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	1.33e-05	0.00179	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PRKAR1A—thyroid cancer	1.32e-05	0.00178	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MINPP1—thyroid cancer	1.32e-05	0.00178	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	1.32e-05	0.00177	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	1.3e-05	0.00175	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	1.29e-05	0.00173	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TSHR—thyroid cancer	1.28e-05	0.00171	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	1.26e-05	0.0017	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	1.26e-05	0.00169	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TSHR—thyroid cancer	1.25e-05	0.00168	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	1.23e-05	0.00165	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HPGD—thyroid cancer	1.23e-05	0.00165	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—SST—thyroid cancer	1.22e-05	0.00164	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.18e-05	0.00158	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MEN1—thyroid cancer	1.17e-05	0.00158	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	1.17e-05	0.00158	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TSHR—thyroid cancer	1.16e-05	0.00156	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—SST—thyroid cancer	1.15e-05	0.00155	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PTCH1—thyroid cancer	1.14e-05	0.00154	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PRKAR1A—thyroid cancer	1.14e-05	0.00153	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	1.13e-05	0.00152	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.12e-05	0.00151	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	1.12e-05	0.00151	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CALCA—thyroid cancer	1.11e-05	0.00149	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TSHR—thyroid cancer	1.09e-05	0.00147	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TCF7L1—thyroid cancer	1.09e-05	0.00146	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	1.08e-05	0.00145	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	1.06e-05	0.00143	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	1.06e-05	0.00143	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CHST14—thyroid cancer	1.06e-05	0.00142	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—SST—thyroid cancer	1.05e-05	0.00141	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MEN1—thyroid cancer	1.03e-05	0.00138	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CALCA—thyroid cancer	1.01e-05	0.00135	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—SST—thyroid cancer	9.92e-06	0.00133	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTCH1—thyroid cancer	9.85e-06	0.00132	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	9.73e-06	0.00131	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	9.73e-06	0.00131	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SST—thyroid cancer	9.71e-06	0.0013	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CALCA—thyroid cancer	9.55e-06	0.00128	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TCF7L1—thyroid cancer	9.35e-06	0.00126	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CALCA—thyroid cancer	9.35e-06	0.00126	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	9.31e-06	0.00125	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSHR—thyroid cancer	9.25e-06	0.00124	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CDK1—thyroid cancer	9.12e-06	0.00122	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	9.1e-06	0.00122	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—SST—thyroid cancer	9.01e-06	0.00121	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MEN1—thyroid cancer	8.7e-06	0.00117	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CALCA—thyroid cancer	8.67e-06	0.00116	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MINPP1—thyroid cancer	8.64e-06	0.00116	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HPGD—thyroid cancer	8.52e-06	0.00114	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SST—thyroid cancer	8.52e-06	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDK1—thyroid cancer	8.46e-06	0.00114	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	8.37e-06	0.00112	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	8.27e-06	0.00111	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CALCA—thyroid cancer	8.2e-06	0.0011	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TPR—thyroid cancer	8.18e-06	0.0011	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PRKAR1A—thyroid cancer	8.05e-06	0.00108	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSHR—thyroid cancer	7.95e-06	0.00107	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	7.87e-06	0.00106	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CDK1—thyroid cancer	7.85e-06	0.00105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRKAR1A—thyroid cancer	7.82e-06	0.00105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MEN1—thyroid cancer	7.47e-06	0.001	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDK1—thyroid cancer	7.42e-06	0.000997	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NDUFA13—thyroid cancer	7.35e-06	0.000987	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SST—thyroid cancer	7.2e-06	0.000967	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	7.12e-06	0.000956	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TPR—thyroid cancer	7.04e-06	0.000946	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CALCA—thyroid cancer	6.93e-06	0.000931	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	6.93e-06	0.00093	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CHST14—thyroid cancer	6.91e-06	0.000928	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSHR—thyroid cancer	6.84e-06	0.000919	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRG1—thyroid cancer	6.79e-06	0.000913	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTCH1—thyroid cancer	6.76e-06	0.000908	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRKAR1A—thyroid cancer	6.73e-06	0.000904	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MEN1—thyroid cancer	6.43e-06	0.000864	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDK1—thyroid cancer	6.27e-06	0.000842	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SST—thyroid cancer	6.18e-06	0.00083	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SLC5A5—thyroid cancer	6.13e-06	0.000823	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TERT—thyroid cancer	6.1e-06	0.000819	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRG1—thyroid cancer	5.96e-06	0.0008	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALCA—thyroid cancer	5.95e-06	0.000799	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	5.83e-06	0.000784	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTCH1—thyroid cancer	5.82e-06	0.000782	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HPGD—thyroid cancer	5.57e-06	0.000748	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDK1—thyroid cancer	5.38e-06	0.000723	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TERT—thyroid cancer	5.35e-06	0.000718	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SST—thyroid cancer	5.32e-06	0.000715	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC5A5—thyroid cancer	5.27e-06	0.000708	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RXRA—thyroid cancer	5.15e-06	0.000691	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	5.14e-06	0.00069	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALCA—thyroid cancer	5.12e-06	0.000688	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	5.11e-06	0.000687	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRG1—thyroid cancer	5.03e-06	0.000676	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TPR—thyroid cancer	4.89e-06	0.000657	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BRAF—thyroid cancer	4.83e-06	0.000649	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	4.81e-06	0.000647	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDK1—thyroid cancer	4.64e-06	0.000623	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TERT—thyroid cancer	4.52e-06	0.000607	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	4.51e-06	0.000605	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RXRA—thyroid cancer	4.43e-06	0.000595	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	4.42e-06	0.000594	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRG1—thyroid cancer	4.32e-06	0.000581	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	4.32e-06	0.000581	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BRAF—thyroid cancer	4.23e-06	0.000569	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—thyroid cancer	3.88e-06	0.000521	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	3.88e-06	0.000521	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	3.81e-06	0.000512	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	3.76e-06	0.000505	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRG1—thyroid cancer	3.72e-06	0.0005	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	3.71e-06	0.000499	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC5A5—thyroid cancer	3.66e-06	0.000492	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	3.65e-06	0.000491	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—thyroid cancer	3.58e-06	0.000481	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—thyroid cancer	3.52e-06	0.000474	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—thyroid cancer	3.4e-06	0.000457	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—thyroid cancer	3.34e-06	0.000449	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	3.32e-06	0.000446	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	3.3e-06	0.000443	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	3.28e-06	0.00044	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	3.27e-06	0.000439	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—thyroid cancer	3.25e-06	0.000437	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	3.2e-06	0.000431	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TPR—thyroid cancer	3.2e-06	0.00043	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	3.2e-06	0.000429	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.15e-06	0.000423	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—thyroid cancer	3.09e-06	0.000415	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RXRA—thyroid cancer	3.08e-06	0.000413	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—thyroid cancer	3.07e-06	0.000413	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—thyroid cancer	3.04e-06	0.000408	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—thyroid cancer	2.98e-06	0.000401	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	2.91e-06	0.000391	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	2.82e-06	0.000378	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.81e-06	0.000378	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—thyroid cancer	2.8e-06	0.000376	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	2.79e-06	0.000374	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	2.71e-06	0.000364	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—thyroid cancer	2.66e-06	0.000358	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—thyroid cancer	2.65e-06	0.000356	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—thyroid cancer	2.61e-06	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—thyroid cancer	2.61e-06	0.000351	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—thyroid cancer	2.56e-06	0.000343	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—thyroid cancer	2.52e-06	0.000339	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	2.46e-06	0.00033	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	2.42e-06	0.000326	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.39e-06	0.000322	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	2.39e-06	0.000321	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	2.33e-06	0.000312	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—thyroid cancer	2.32e-06	0.000312	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—thyroid cancer	2.29e-06	0.000308	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—thyroid cancer	2.25e-06	0.000302	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—thyroid cancer	2.24e-06	0.000301	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—thyroid cancer	2.23e-06	0.000299	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—thyroid cancer	2.22e-06	0.000298	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—thyroid cancer	2.2e-06	0.000295	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—thyroid cancer	2.17e-06	0.000291	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	2.11e-06	0.000284	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	2.06e-06	0.000277	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—thyroid cancer	2.04e-06	0.000274	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RXRA—thyroid cancer	2.01e-06	0.00027	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	2e-06	0.000269	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—thyroid cancer	1.96e-06	0.000263	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—thyroid cancer	1.95e-06	0.000262	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—thyroid cancer	1.94e-06	0.000261	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—thyroid cancer	1.94e-06	0.00026	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.93e-06	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—thyroid cancer	1.93e-06	0.000259	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—thyroid cancer	1.92e-06	0.000258	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—thyroid cancer	1.86e-06	0.00025	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	1.82e-06	0.000244	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—thyroid cancer	1.72e-06	0.000231	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—thyroid cancer	1.72e-06	0.000231	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—thyroid cancer	1.66e-06	0.000223	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.66e-06	0.000223	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—thyroid cancer	1.65e-06	0.000221	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.53e-06	0.000205	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.48e-06	0.000199	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—thyroid cancer	1.45e-06	0.000195	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—thyroid cancer	1.43e-06	0.000192	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.41e-06	0.00019	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—thyroid cancer	1.33e-06	0.000179	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—thyroid cancer	1.28e-06	0.000173	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—thyroid cancer	1.27e-06	0.000171	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—thyroid cancer	1.27e-06	0.000171	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.25e-06	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—thyroid cancer	1.22e-06	0.000163	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—thyroid cancer	1.11e-06	0.000148	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—thyroid cancer	1.07e-06	0.000144	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.99e-07	0.000134	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—thyroid cancer	8.71e-07	0.000117	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—thyroid cancer	7.68e-07	0.000103	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—thyroid cancer	5.02e-07	6.75e-05	CbGpPWpGaD
